PELF is More Active than FAMTX in Metastatic Gastric Carcinoma (MGC)

Li Liu, MD

University of Pennsylvania Cancer
Ultima Vez Modificado: 14 de mayo del 2001

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

ASCO: Dabrafenib/Trametinib Active in Metastatic Melanoma

May 18, 2012

Phase I/II study shows combo is tolerated in patients with V600 BRAF-mutant solid tumors

ASCO: Trametinib Improves Survival in Metastatic Melanoma

Jun 5, 2012

For patients with V600E, V600K BRAF mutations, trametinib improves survival versus chemo

Vismodegib Has Antitumor Activity in Basal Cell Carcinoma

Jun 7, 2012

And, the hedgehog pathway inhibitor prevents, treats BCC in patients with basal cell nevus syndrome